NEAT1 and cancer: To further study the m6A modification of NEAT1–1 in a clinicopathologically relevant context, we harvest the RNA immunoprecipitated by m6A antibody from fresh sample of adjacent normal cancer, primary cancer, lymph node-metastasis cancer and bone-metastatic cancer.